| Product Code: ETC6101649 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Angola Pharmacogenetic Testing Market Overview |
3.1 Angola Country Macro Economic Indicators |
3.2 Angola Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Angola Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Angola Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Angola Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Angola Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Angola Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Angola Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Angola Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Angola Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Angola Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Angola Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about personalized medicine and its benefits |
4.2.2 Growing prevalence of chronic diseases in Angola |
4.2.3 Government initiatives to improve healthcare infrastructure and services |
4.3 Market Restraints |
4.3.1 Lack of skilled healthcare professionals to interpret pharmacogenetic test results |
4.3.2 High costs associated with pharmacogenetic testing |
4.3.3 Limited access to advanced healthcare facilities in remote areas of Angola |
5 Angola Pharmacogenetic Testing Market Trends |
6 Angola Pharmacogenetic Testing Market, By Types |
6.1 Angola Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Angola Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Angola Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Angola Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Angola Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Angola Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Angola Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Angola Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Angola Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Angola Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Angola Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Angola Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Angola Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Angola Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Angola Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Angola Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Angola Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Angola Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Angola Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Angola Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Angola Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Angola Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Angola Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Angola Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Angola Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Angola Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Angola Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Angola Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Angola Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Angola Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Angola Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Angola Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Angola Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Angola Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Angola Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Angola Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Angola Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Angola Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Angola Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Angola Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Angola Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Angola Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Angola Pharmacogenetic Testing Market Export to Major Countries |
7.2 Angola Pharmacogenetic Testing Market Imports from Major Countries |
8 Angola Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of healthcare professionals trained in pharmacogenetic testing |
8.2 Adoption rate of pharmacogenetic testing by healthcare providers |
8.3 Percentage of population covered by healthcare facilities offering pharmacogenetic testing |
9 Angola Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Angola Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Angola Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Angola Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Angola Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Angola Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Angola Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Angola Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Angola Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Angola Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Angola Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here